Xencor (XNCR) PT Raised to $63 at Piper Sandler After Presenting Preclinical Data on 4 New Programs
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff raised the price target on Xencor, Inc. (NASDAQ: XNCR) to $63.00 (from $60.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
